Search Results
Statements by CMS Leadership on Historic Announcement of First Selected Drugs for Medicare Drug Price Negotiation
Press Release
CMS Releases Revised Guidance for Historic Medicare Drug Price Negotiation Program
For the first time, Medicare will negotiate prices directly with drug companies on behalf of people with Medicare, improving affordability for some of the costliest prescription drugs
Press Release CMS Office of the Actuary Releases 2022-2031 National Health Expenditure Projections
Average annual growth in national health spending over the next decade projected to be 5.4%
Press Release Inflation Reduction Act Continues to Lower Out-of-Pocket Prescription Drug Costs for Drugs with Price Increases Above Inflation
HHS announces savings for some people with Medicare on 43 Part B prescription drugs
Press Release CMS announces plan to ensure availability of new Alzheimer’s drugs
Agency outlines how people with Medicare can get these drugs if FDA grants traditional approval
Press Release Biden-Harris Administration Announces Proposal to Advance Prescription Drug Transparency in Medicaid
New HHS proposal would shed light on cost of prescription drugs and save states and federal government money in Medicaid
Press Release Medicaid Drug Price Verification Survey and Pharmacy Benefit Manager Drug Price Transparency
Fact Sheet
Increased Use of Telehealth Services and Medications for Opioid Use Disorder During the COVID-19 Pandemic Associated with Reduced Risk for Fatal Overdose
Study findings support the continuation of providing telehealth services for opioid use disorder and its related care
Press Release